πŸ‡ΊπŸ‡Έ FDA
Patent

US 10266549

ULK1 inhibitors and methods using same

granted A61KA61K31/505A61K31/506

Quick answer

US patent 10266549 (ULK1 inhibitors and methods using same) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/505, A61K31/506, A61K31/5377, A61K31/5383